MEPHARMA and ValGenesis Announce Strategic Partnership to Advance Pharmaceutical Quality Management
MEPHARMA Consultancy DWC-LLC and ValGenesis have announced a strategic partnership aimed at transforming and digitizing pharmaceutical quality management processes across the MENA region. This collaboration brings together MEPHARMA’s expertise in regulatory compliance and quality assurance with ValGenesis’ market-leading cloud-based Validation Lifecycle Management System (VLMS).
By leveraging ValGenesis’ innovative VLMS, pharmaceutical and biotechnology companies in the MENA region will be empowered to streamline their validation processes, improve compliance, and enhance operational efficiency. ValGenesis’ VLMS automates the validation lifecycle, simplifying compliance with regulatory requirements and ensuring data integrity throughout the process.
Ayman Mahmoud, General Manager at MEPHARMA Consultancy DWC-LLC, expressed excitement about the partnership, stating, “This collaboration aligns perfectly with our commitment to delivering comprehensive compliance solutions and driving industry-wide innovation.”
Bo Olsen, ValGenesis’ SVP of Partners, echoed this sentiment, saying, “Together, we provide well-defined, robust validation lifecycle management strategies and solutions that enable companies to adhere to the most stringent global regulatory requirements.”
The partnership between MEPHARMA Consultancy DWC-LLC and ValGenesis signifies a significant milestone in the pharmaceutical industry, where compliance with regulatory standards and efficient quality management are essential for success. By combining their expertise and technology, both companies are poised to deliver exceptional value to their clients, ensuring compliance, mitigating risks, and driving innovation in the ever-evolving pharmaceutical landscape.
For more information about MEPHARMA Consultancy DWC-LLC and ValGenesis, please visit MEPHARMA’s and ValGenesis’ website.
About MEPHARMA: MEPHARMA Consultancy DWC-LLC is a leading consultancy firm specializing in regulatory compliance, quality assurance, and validation services for the pharmaceutical industry. With a team of highly experienced professionals, the company provides comprehensive solutions to ensure compliance with global regulatory standards and optimize quality management practices.
About ValGenesis: ValGenesis, Inc. is the creator of an innovative software platform that serves as a foundation for managing compliance-based validation activities in life science companies. ValGenesis, Inc. is the provider of the first enterprise application that manages the corporate validation lifecycle process. This solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. For more information, visit ValGenesis’ website.